Cite

HARVARD Citation

    Jain, P. et al. (2022). Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Journal of clinical oncology. 40 (2), pp. 202-212. [Online]. 
  
Back to record